期刊文献+

强化干预对社区高血压伴代谢综合征人群心脑血管事件影响 被引量:7

Influence of strengthen intervention to hypertension with metabolic syndrome in community population
下载PDF
导出
摘要 目的:了解药物综合干预对社区高血压伴代谢综合征人群心脑血管事件的影响。方法:采用随机整群抽样南宁市两个社区的1215人为研究对象,随机分成强化干预组和对照组。强化干预组按照是否患有高血压及其相关疾病分别采取不同的强化治疗方案进行干预;对照组人员维持志愿就诊和志愿服药的正常医疗状态,随访43.5个月,记录发生心脑血管事件情况。结果:前瞻性随访研究43.5个月后结果,①两组高血压和MS患者收缩压和舒张压较干预前明显降低(P<0.01);其中干预组较对照组下降更明显(P<0.01或0.05);②高血压伴MS患者收缩压和舒张压分别降低了14.11、7.59mmHg和6.59、5.57mmHg,除对照组收缩压外,均较干预前明显降低(P<0.01)。③本组心脑血管事件发生率为4.0%,高血压明显高于非高血压者(P<0.01),其中对照组无论高血压或非高血压者均明显高于干预组(P<0.01或<0.05)。④高血压伴MS者事件发生率为4.2%,高于非高血压和非MS者,低于高血压组或MS组,但均无显著性差异(P>0.05)。结论:综合强化干预可明显降低社区高血压、高血压伴代谢综合征人群血压水平,降低心脑血管事件发病风险。 Objective To understand the impact of comprehensive drug intervention on happen of cardiovascular and cerebrovascular events in patients with hypertension with metabolic syndrome (MS) .Method We used a random cluster sampling of nanning city in line with the two communities included in the standard 1 215 as an integrated intervention in the treatment of subjects,which were randomly divided into strengthening intervention group and the control group.Strengthening intervention group received the different strengthening intervention according to whether the patients suffered from hypertension or not and its related diseases;in the control group,remained voluntary medical staff.The follow-up time was 43.5 months and the cardiovascular and cerebrovascular events were recorded.Results After 43.5 months of forward-looking follow-up study,①Systolic and diastolic blood pressure were significantly lower than that of before intervention in the patients with hypertension with MS in two groups(P〈0.01) ;one intervention group than in the control group decreased more significantly (P〈0.01 or 0.05) ;②The systolic and diastolic blood pressure reduced 14.11,7.59 mm Hg and 6.59,5.57 mm Hg in patients with hypertension with MS,all significantly lower than before intervention(P〈0.01) ,except the control group;③The cardiovascular and cerebrovascular event incidence in this group was 4.0% ,and that of hypertension patients were significantly higher than non-hypertensive (P〈0.01) ,and in the control group,whether with hypertension or not,the cardiovascular and cerebrovascular event incidence were significantly higher than the intervention group(P〈0.01 or P〈0.05) ;④The incidence of hypertension with MS were 4.2% ,higher than the non-hypertensive and non-MS patients,and lower than the hypertension or the MS group,but had no significant difference(P〉0.05) .Conclusion Comprehensive strengthen intervention can significantly lower the blood pressure levels of community hypertension and hypertension with MS,and reduce their incidence of cardiovascular and cerebrovascular events risk.
出处 《吉林医学》 CAS 2010年第22期3672-3675,共4页 Jilin Medical Journal
基金 广西科技攻关项目(桂科攻0472002-19) 中央保健专项资金科研课题(0627160)
关键词 高血压 代谢综合征 社区人群 心血管事件风险 随访 Hypertension Metabolic syndrome Community groups Risk of cardiovascular events Follow-up
  • 相关文献

参考文献7

  • 1Lakka HM,Laaksonen DE,Lakka TA,et al.The metabolic syndrome and total cardiovascular disease mortality in middle-aged men[J].JAMA,2002,288(10):2709.
  • 2Giuseppe S,Matteo P,Gaetano V,et al.Prognostic value of the metabolic syndrome in essential hypertension[J].J Am Coll Cardiol,2004,43(9):1817.
  • 3Third report of the National Cholesterol Education Program(NCEP).Expert panel on detection,evaluation,and treatment of high blood cholesterol in adults(Adult Treatment PanelⅢ) Final report[J].Circulation,2002,106(16):3143.
  • 4Mule G,Nardi E,Cottone S,et al.Influence of metabolic syndrome on hypertension-related target organ damage[J].J Intern Med,2005,257(3):503.
  • 5Leoncini G,Ratto E,Viazzi F,et al.Metabolic syndrome is associated with early signs of organ damage in nondiabetic,hypertensive patients[J].J Intern Med,2005,257(3):454.
  • 6Schillaci G,Pirro M,Vaudo G,et al.Prognostic value of the metabolic syndrome in essential hypertension[J].J Am Coll Cardiol,2004,43(10):1817.
  • 7闻静,华琦,谭静,邢绣荣,刘荣坤,杨峥.原发性高血压患者代谢综合征发病情况的调查与分析[J].中华老年心脑血管病杂志,2007,9(8):512-514. 被引量:12

二级参考文献7

  • 1顾东风,Reynolds K,杨文杰,陈恕凤,吴锡桂,段秀芳,蒲晓东,徐丽华,吴先萍,陈祥福,魏仁敏,陈娜萦,吴天一,王礼桂,姚才良,牟建军,马义峰,王晓飞,Whelton P,何江.中国成年人代谢综合征的患病率[J].中华糖尿病杂志(1006-6187),2005,13(3):181-186. 被引量:580
  • 2邹密,蒋利,钟健,倪银星,徐兴森,闫振成,陈静,赵志钢,祝之明.非糖尿病代谢综合征与颈动脉粥样硬化的研究[J].中华老年心脑血管病杂志,2007,9(5):323-325. 被引量:14
  • 3Giuseppe S,Matteo P,Gaetano V,et al.Prognostic value of the metabolic syndrome in essential hypertension[J].J Am Coll Cardiol,2004,43:1817-1822.
  • 4Garcia-Puig J,Ruilope LM,Luque M,et al.Glucose metabolism in patients with essential hypertension[J].Am J Med,2006,119:318-326.
  • 5Morse SA,Zhang R,Tharur V,et al.Hypertension and the metabolic syndrome[J].Am J Med Sci,2005,330:303-310.
  • 6Muller M,Grobbee DE,Tonkelaar I,et al.Endogenous sex hormones and metabolic syndrome in aging men[J].Clin Endocrinol Metab,2005,90:2618-2623.
  • 7Glseder B,Cip P,Malaimare L,et al.The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than inmen[J].Stroke,2005,36:1212-1217.

共引文献11

同被引文献34

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部